Related Experiment Video

Updated: Jul 2, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K

The National Non-Hodgkin Lymphoma Audit: Insights and Impact

R Kanani1, K Walker2, L Han2

  • 1Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|February 27, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Auditnon-Hodgkin lymphomaoutcomesquality improvement

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.7K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.5K

Related Experiment Videos

Last Updated: Jul 2, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.7K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.5K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Articles linked to this work by shared authors, journal, and citation graph.

Prevalence, associated factors, management and outcomes of hypokalaemia in hospitalised patients at a South African tertiary centre.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025

A 16-Year-Old with a Mycoplasma hominis Empyema Post-Lung Transplantation: A Case Report.

Pediatric transplantation·2025

CBCT in contemporary endodontics.

Australian dental journal·2023

Assessing the barriers and enablers to the implementation of the diagnostic radiographer musculoskeletal X-ray reporting service within the NHS in England: a systematic literature review.

BMC health services research·2023

Patients' and clinicians' perspectives towards primary care consultations for shoulder pain: qualitative findings from the Prognostic and Diagnostic Assessment of the Shoulder (PANDA-S) programme.

BMC musculoskeletal disorders·2023

Robust deep learning-based protein sequence design using ProteinMPNN.

Science (New York, N.Y.)·2022

Analysis of Lymphopenia in Patients with Stage III Non-small Cell Lung Cancer Treated with Chemoradiotherapy and Consolidation Immunotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

A Systematic Review and Meta-Analysis of the Prognostic Value of Tumor Response Measurements During Radiotherapy for Head and Neck cancers.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Definitive Stereotactic Body Radiotherapy for Unresectable Primary Bone and Soft Tissue Tumors: A Single-institution Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Radiotherapy Treatment and Beyond - Mapping Radiotherapy Late Effects Service Provision in England.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Assessing the Benefit of Adjuvant Chemotherapy in Rectal Cancer: An International Real-World Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Endoscopic Salvage Following Radiotherapy for Oesophageal Cancer: A Systematic Review.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Phylogenetic and Genomic Feature Analysis of Cutaneous Nocardia Isolates.

Infection and drug resistance·2026

Predictive Role of Neutrophil-to-Lymphocyte Ratio and Serum Creatinine in the Early Detection of Sepsis-Related Organ Dysfunction.

Cureus·2026

Phagocytosis of SARS-CoV-2 Nucleocapsid- and RNA-Containing Immune Complexes Drives Inflammatory Cytokine Production and Endothelial Dysfunction.

bioRxiv : the preprint server for biology·2026

Tuberomammillary histaminergic neurons are not required for behavioral responses in a Nitroglycerin-Induced acute headache mouse model.

Neuroscience letters·2026

Sex differences in patients with narcolepsy type 1: Clinical manifestations, sleep profiles, and symptoms evolution.

Sleep medicine·2026

Therapeutic Potential of NLRP3 Inhibitor MCC950 in Aging Mice Stroke Outcomes.

Translational stroke research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us